as extraneous viruses, do not compromise the safety of the final product.
In addition to developing guidelines for the quality control of the substances themselves, the EEC is presently considering the pre-clinical safety testing of new products derived by modern biotechnology. These products pose special problems since, in general, classical toxicological studies in animals as applied to chemical drugs may be of only limited relevance. For example, certain proteins, such as human interferons, are highly species-specific and are thus much more pharmacologically active in man than in any other animal species. In addition, the amino acid sequences of human proteins will often be significantly different from their natural counterparts in other animals. These proteins therefore frequently produce immunological responses in foreign hosts which may ultimately modify their biological effects and which may result in toxicity due to immune complex formation. Such toxicity would, of course, have little bearing on the safety of the product in man, the intended recipient. Nevertheless, preclinical safety testing is important, especially where repeated, large or non-physiological doses of a particular product may be required for a given therapeutic effect, and knowledge of its biological effects in man remains incomplete.
Since 1 July 1987 there has been a requirement that all product licence applications for biotechnologyderived biologicals within the EEC be referred to the Committee for Proprietary Medicinal Products or the Committee for Veterinary Medicinal Products, as the case may be, in Brussels, for an opinion's". Member States are required to take this opinion into consideration when considering the licensing of the product in question. It is hoped that the experience gained from this newly established system will help decide the most appropriate European regulatory procedures for the next decade. This development forms part of the EEC's increasing activity in developing a Communitywide framework for regulating biotechnology. It includes not only the elaboration of procedures to harmonize the regulatory approaches of Member States with regard to the licensing of biological medicines, but also procedures for regulating the levels of containment for genetically engineered organisms in enclosed manufacturing systems, as well as the control of planned release of genetically engineered organisms into the environment. In recent years a number of numerically based methods, including decision-support systems, diagnostic systems, expert systems and decision analysis, have been applied to medical practice. Whilst succeeding in pilot sites, they have failed to become part of routine medicine. Two recent reviews summarize the current position regarding decision analysis'r'. This technique was developed in the 1940s by Abraham Wald", It gives a complete and coherent description, in numerical terms, ofdecision-making under uncertainty. The advantages ofdecision analysis include guidance on which decision to take, and comparison of the effects of different decisions taken under similar circumstances. 'What if . . .1' questions can be asked to note the effects of changing the initial conditions. This tests the stability of a decision and determines the circumstances required for the decision to change. Finally, the method is objective and hence reproducible.
M F Cuthbert
Critics have pointed out some difficulties with the technique. It is said to be a complex topic, little understood by the majority, with only a few individuals able to teach it and develop it further. Using decision analysis can be time-consuming and the results are inevitably an approximation, not fully reflecting the real situation. Doctors wishing to use the method have to work in the unfamiliar environment ofmathematics and computers.
Protagonists'' argue that the method makes the decision process explicit, giving the opportunity for the elements of a decision to be isolated and examined. This provides a framework to determine reasons why different decisions occur in similar situations. Patient interests are accounted for, as their preferences can be specifically included in the method.
Of the many tasks performed by doctors, the most pre-eminent is decision-making. Even those specialties demanding great manual dexterity are firmly embedded in the decision-making skills of its practitioners. Improving such a key task should improve the standard of patient care.
For about 15 years many attempts to introduce decision theory into medicine were tried with only limited success. It is another example of formal and usually mathematical methods, including computerbased medical records systems, which seem to have so much to offer but which are only weakly embraced by the profession. These formal methods have many common characteristics. They all involve order, classification and usually the manipulation of numbers. They nearly always depend on technologies, i.e, computer terminals, not commonly used in medical practice. These technologies require skills that are useful generally but not central to medical practice. Typing, the ability to run computer programs to solve problems and the power logically to structure information may be helpful far beyond the bounds of clinical care, but are often an obstruction to routine medical practice.
Formal systems are not usually adaptable to an individual's way of working. The techniques are not commonly available at the bedside or in the consulting room. Having to adapt normal working routines to use these systems makes them less attractive. The results or suggestions are often produced by unknown methods. This leads to doubt as to their reliability and wavering on whether they should be accepted.
It is argued, with much justification, that many of these features are changing. User friendliness is the key characteristic sought. Computers are smaller and more portable, and various devices such as touch screens, light pens and the mouse obviate the need for keyboard skills. Systems are designed so that the user is always aware of where he is, what the options are for the next move, and which one is the most suitable for his requirements. Outputs can be customarized so that they reflect the needs of the individual user.
Cheapness of personal computers and their extensive use in schools and universities have produced a generation very familiar with these technologies. This must make their adoption more likely, but it is not the whole answer. The commonest mathematical method used in diagnostic systems and decision analysis is Bayes' Theorum, first enunciated over 200 years ago. It demands no more than simple arithmetic, though the calculations may be very extensive. The probability theory involved is equally straightforward. Since the universal introduction of elementary education in the late 19th century, virtually the whole population has learned the arithmetic skills required for Bayes' Theorum. Yet it is far from universally used in the care of patients.
The root cause of this basic neglect is much deeper. The professions can be divided into those which are numerate and those which are not. Medicine clearly is non-numerate in comparison with engineering. The practice of medicine involves numbers, but it does not organize itselfaround them. There are, ofcourse, many areas which depend heavily on numbers -for example, Journal of the Royal Society of Medicine Volume 81 March 1988 129 the fields of epidemiology, pharmacokinetics and radiotherapy -and, of course, virtually all research is supported and helped by statistical techniques. Nonetheless, it can be argued that medicine is essentially non-numerate. Its principal activities of patient care do not depend, except remotely, on the use of numbers and mathematical techniques.
Numeracy and non-numeracy carry other implications: formal and non-formal, structured and nonstructured, systematic and non-systematic, explicit and intuitive ways of making decisions. Those disciplines which are numerate and have the other characteristics absorb the new formal methods more readily than the non-numerate disciplines.
Is there a role for techniques such as decision analysis, which appears to have clear benefits in providing an objective way ofmaking decisions but yet is not attractive to the majority of practitioners? There are many situations in medicine -the management of the solitary pulmonary nodule, the investigation of the acute abdomen, determining the cause of raised intercranial pressure, the investigation of the pancreas -where the manner of proceeding is not always clear. This suggests there is a case for having specialist departments dealing in techniques like decision analysis. They would gather data, perform the analysis and publish the results. These publications could guide and assist the normal practitioner in his daily work. The decision analysts could also indicate when sufficient information is lacking to make a clear choice, where better options might be chosen and how the decision might alter with changes in circumstances.
How to bring decision analysis into patient care is one aspect of the larger problem which encompasses the use offormal methods in medicine. It seems clear that they will never be universally used, even though they can produce benefits, including more accurate diagnoses, better patient care and better decisions.
A thoughtful doctor is often in the position where he does not know the answer. The availability of an objective and systematic approach to his problem, with the opportunity to learn and consider the reasons for a particular recommendation, could be a great help.
D W Young

Consultant Physician St Chad's Hospital. Birmingham
